Human Growth Hormone Replacement Therapy Using a Pre-Cursor Secretagogue Analog (Sermorelin)
A Secretagogue is a substance that promotes secretion or release, for instance the Secretagogue for Human Growth Hormone production, ie. The substance that tells your pituitary gland to increase HGH production is GHRH (growth Hormone Releasing Hormone).
Sermorelin is a polypeptide chain that mimics the effects of Growth Hormone Releasing Hormone – the substances that naturally tells your pituitary gland to increase HGH production.
Growth Hormone Releasing Hormone (GHRH) Therapy:
Sermorelin, is a Human Growth Hormone HGH “Secretagogue” delivered through subcutaneous Injection – GH-RH (1-29)
Growth hormone deficiency in adults occurs when the naturally occurring pituitary hormone known as Human Growth Hormone is produced in inadequate quantities with a resulting deficiency in growth hormone and IGF-1 levels in the blood stream. Growth hormone deficiency includes a spectrum that ranges from a complete lack of growth hormone through various degrees of partial growth hormone deficiency. Most people after the age of 25 to 30 begin a process of human growth hormone deficiency that accelerates at a loss rate of 1 to 2% per year, depending on ones own genetic makeup, diet, exercise and lifestyle.
In contrast to supplementing the growth hormone deficiency through injections of exogenous recombinant Human Growth Hormone (HGH), another therapy, GH-RH therapy involves the use of GH-RH injections that cause the body’s pituitary gland to secrete greater quantities of naturally produced Human Growth Hormone. The body therefore naturally produces its own growth hormone to supplement the deficiency as a result of GH-RH therapy.
See: HGH Sermorelin
Incoming search terms:
- exogenous injectable hgh
- growth hormone deficiency
- single men
- Sermorelin GH hormone therapy west coast california washington hawaii
- boys with shox gene deficiency
- GH deficiency
- injectable growth hormone secretogogue
- injectable Secretagogue